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EXPERIMENTAL PROCEDURE 
 
ANIMALS 
Fourty-four male Sprague-Dawley rats (~8 weeks old) were used throughout the studies. The animals were single-housed 
in a standard animal facility with a 12–12 hr light–dark cycle, with food and water available ad libitum. All procedures were 
performed during the light phase and in accordance with the University of Nevada, Las Vegas Animal Care and Use 
Committee and NIH guidelines for ethical treatment of research subjects. 
 
DRUG ADMINISTRATION 
Rats were randomly distributed into four groups. To induce DM, stereotaxic surgeries were performed under aseptic 
conditions and ketamine/dexmedetomidine anesthesia (Kinney et al., 2003; Sabbagh et al., 2012). In two of the groups, 
bilateral injections of streptozotocin (STZ; 25 mg/ml; 8 ml/ventricle) was slowly administered on each site using 
stereotaxic coordinates: 0.7 mm posterior, 1.4 mm lateral to Bregma, and 3.5 mm ventral to the surface of the skull 
(Paxinos & Watson, 2009). The remaining two groups were infused with artificial cerebral spinal fluid (ACSF) to serve as a 
control. A week after the surgeries, a single intraperitoneal injection of either LPS (1.0 mg/ml/kg of body weight) or saline 
(1.0 ml/kg of body weight) were then administered, resulting in the four groups: ACSF/Saline, STZ/Saline, ACSF/LPS, and 
STZ/LPS.  
 
TEMPERATURE AND WEIGHT RECORD 
To ensure LPS induced an immune response, temperatures and weights were recorded after LPS injections. Rectal 
temperatures were monitored for the first 72 hours and then one week later. Body weights were recorded throughout the 
course of the experiment.  
 
MORRIS WATER MAZE 
Spatial learning and memory was tested using the Morris Water Maze spatial learning task two weeks after LPS or saline 
injection. The water maze was conducted using a white, circular polyethylene tank (1.5 m in diameter, 76 cm in height, 
4.77 mm thick) filled with tap water made opaque with white, non-toxic paint, and visually divided into four quadrants for 
analysis. Four different large, colorful shapes and posters on the walls were used as distal spatial cues. Path length, swim 
speed, perimeter time (thigmotaxis), latency, and quadrant location were recorded.  
 
In the experimental trials, rats were allowed to swim for 60 seconds to find the hidden platform (a 10 cm x 10 cm square 
clear plastic located 1.5 cm below the water’s surface) located in one of the four quadrants. If an animal failed to locate 
the platform after 60 seconds, they were guided to the platform. Once on the platform the animal was given 20 seconds to 
orient and familiarize itself to the spatial cues. The trial was repeated in identical fashion three more times, with a 30 
second interval between trials. Four consecutive trials were performed each day for each animal. A tracking system was 
used to record all trials. After five days of training, a probe trial was done where the hidden platform was taken out and 
animals were allowed to search the maze for 60 seconds. The tracking system recorded the amount of time subjects 
spent in all four quadrants, as well as the number of times the animals path crossed over the former platform location 
versus analogous locations in other quadrants. Visible platform training was then conducted wherein the platform was 
raised above water level to ensure motoric and visual function was equivalent between groups.  
 
TISSUE COLLECTION 
Rats were individually euthanized via CO2 asphyxiation, decapitated, and hippocampi and cortices were immediately 
dissected out and frozen. Hippocampi and cortices were homogenized using RIPA buffer (Bolton et al., 2012). 
Homogenization was performed using a handheld Polytron tissue homegenizer (Kinematica Inc). Lysates were 
centrifuged at 15,000 x g for 15 minutes at 4°C, the supernatant was then collected and protein concentration were 
determined using the bicinchoninic acid assay (BCA; Pierce). Samples were frozen and stored at -80°C. Tissue was 
collected four weeks after LPS and saline injections.  
 
SDS PAGE/WESTERN BLOT 
Samples (20 μg) from the hippocampus tissue were separated on 10% SDS-PAGE gels. Proteins were electro-transferred 
to nitrocellulose membranes and blocked for 2 hours. Membranes were then incubated overnight in primary antibody 
(rabbit anti-AβO, 1:1,000 Cell Signaling; rabbit anti-pTau Ser404, 1:1,500, Cell Signaling; mouse anti-Tau, 1:10,000, Cell 
Signaling;  rabbit anti-STEP, 1:1000, Cell Signaling; rabbit anti-NMDAR2B, 1:1000, Cell Signaling; rabbit anti-GluR4, 
1:1000, Cell Signaling) at  4°C. Following incubation, membranes were brought to room temperature, washed three times 
with phosphate buffer saline and Tween (PBSt) for 5 minutes each, and then placed in secondary antibody (IR dye goat 
anti-rabbit 800, 1:5000, Bio-Rad; IR dye goat anti-mouse 680, 1:10000, Bio-Rad) for 1 hour. Membranes were then rinsed 
again in PBSt three times for 5 minutes each and a final 10 minutes PBS wash prior to imaging. Membranes were imaged 
using Odyssey CLx Infrared Imaging System (Li-COR). Band intensity was examined by changing the wavelength 
intensities for the protein of interest and β-Actin for a comparison between groups.  
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INTRODUCTION 
 
         Alzheimer’s disease (AD) is the most common form of dementia, accounting for 50 to 80 percent of all dementia 
cases. This neurodegenerative disease leads to neuronal death and tissue loss in the brain, resulting in the slow 
deterioration of memory, thinking skills, and eventually even the ability perform daily tasks. While it is not a normal part of 
aging, AD is mostly diagnosed in people over the age of 65; thus, the main risk factor for Alzheimer’s disease is increased 
age, though it is most likely other additional factors also contribute (Heese & Akatsu, 2006). Neuropathological hallmarks 
of AD include neurofibrillary tangles (NFTs) formed by the aggregation of hyperphosphorylated tau proteins, and amyloid 
plaques formed by the accumulation of β-amyloid (Aβ) proteins (Cvetkovic-Dozic et al., 2001). To date, the etiology of AD 
remains unknown but several models investigating multiple pathways have been used to better understand the disease. 
            In this experiment, two specific AD risk factors, Type 2 diabetes mellitus (DM) and inflammation of the brain, are of 
interest. Recent evidence has indicated a connection between Alzheimer’s disease and Type 2 DM. The use of the DM 
model to investigate AD represents a useful tool to examine AD pathologies. In Type 2 DM, cells fail to use insulin 
properly, resulting in insulin resistance. This resistance consequently affects the metabolism of tau and Aβ proteins, 
potentially leading to formation or acceleration of NFTs and amyloid plaques characteristically seen in AD (Gasparini et al., 
2002).        
            Chronic brain inflammation, commonly referred to as neuroinflammation, induces a neurotoxic effect by increasing 
Aβ proteins, senile plaques, and neuronal damage, leading to exacerbated symptoms and a more rapid disease 
progression. Alternatively, acute inflammatory responses have been suggested to serve a protective role in degenerative 
disorders (Frank-Cannon et al., 2009). A critical question in AD research is what aspects of chronic neuroinflammation 
exacerbate pathological features, as well as if an acute inflammatory response may play a neuroprotective role by 
reducing the aggregation of Aβ, and thus lowering the likelihood of cell loss. The purpose of this study was to investigate 
the role that acute brain inflammation plays in a diabetic model of AD. In order to examine this, we investigated if an acute 
immune response induced by lipopolysaccharide (LPS) would alter AD related behavioral or pathological features using 
the streptozotocin (STZ) diabetic model of AD.  
RESULTS 
LPS Effects 
Figure 1 The body weights of the animals injected with LPS were lower than the control animals (Figure 1A) and 
the rectal temperatures (Figure 1B) were significantly increased the first 2 days following the days of injection, 
suggesting that an immune response was indeed induced and the change in body weight and temperature was not 
due to any other factor.  
250	
300	
350	
400	
450	
500	
Pr
e-
IC
V	 1	 2	 3	 4	 5	 6	 7	
Pr
e-
LP
S	 1	 2	 3	 10
	
17
	
24
	
30
	
W
e
ig
h
t 
(g
) 
Post-ICV Day                                                                      P ost-LPS Day 
ACSF/Saline	
STZ/Saline	
ACSF/LPS	
STZ/LPS	
A 
     ** 
     ** 
36	
36.2	
36.4	
36.6	
36.8	
37	
37.2	
37.4	
37.6	
37.8	
38	
Pre-LPS	 Day	1	 Day	2	 Day	3	 Day	10	
T
e
m
p
e
r
a
tu
r
e
 (
C
°)
 
                                                 Post-LPS Day 
ACSF/Saline 
STZ/Saline 
ACSF/LPS 
STZ/LPS 
B 
Morris Water Maze  
Figure 2 The analysis of the MWM indicated that the STZ/Saline group exhibited learning deficits consistent with AD 
(significant difference versus ACSF/Saline), whereas the STZ/LPS group did not exhibit these same deficits. STZ/Saline 
animals had significantly longer path lengths during hidden training than all other groups (Figure 2A). During the probe trial, 
all groups spent significantly more time in the target quadrants versus the other three quadrants (selective search) except 
for STZ/Saline animals (Figure 2B).  
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CONCLUSIONS 
• STZ impaired learning and memory, consistent with AD.  
• LPS rescued STZ-induced learning deficit.  
• STZ increased oligomeric Aβ, like AD.  
• Total Aβ oligomers were reduced in STZ/LPS group compared to STZ  
     group alone, indicating LPS may have reduced the AβO increase. 
•  pTau was significantly increased in the STZ/Saline and STZ/LPS groups.  
• A significant decrease was observed in the abundance of the NMDA receptor subunit 
NR2A in the STZ/Saline group, but not in STZ/LPS group. No significant differences 
were observed for the NR2B subunit.  
• The changes in NMDA subunits suggest the immune response may have rescued the 
reduction in NR2A, and may be related to the lack of impairment in spatial learning.        
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Figure 5 Western blot analysis of NMDA receptor subunits NMDA NR2A showed a significant 
decrease in the STZ/Saline group when compared to the control group, ACSF/Saline (* p < 0.05; 
Figure 5A). Western blot analysis of NMDA NR2B (Figure 5A) showed no significant differences 
between groups. Representative WB images of NMDA NR2A and NMDA NR2B can be seen in 
Figure 4B, 4D respectively.  
Learning and Memory Mechanisms 
Figure 4 Western blot analysis of pTau at Serine 404 in hippocampus indicated significantly higher 
levels for both the STZ/Saline group and STZ/LPS groups (* p < 0.05; Figure 4A). Representative 
images can be seen in Figure 4B. Western blot analysis of striatal-enriched protein tyrosine 
phosphatase (STEP) in hippocampus shows no significant differences between groups (Figure 4C), 
indicating that an alteration in STEP is not responsible for the hyperphosphorylation of tau. 
Representative images can be seen in Figure 4D.  
SDS PAGE/Western Blot 
Figure 3 Western blot analysis of Aβ oligomers in hippocampus indicated that there was a significant increase in total Aβ 
oligomers as well as several specific oligomers in the STZ/Saline group (* p < 0.05; Figure 3A-E). The STZ/LPS group did 
exhibit a significant increase in total oligomeric versus the control group but significantly lower than the STZ/Saline group (# p 
< 0.05; Figure 3A). Several Aβ oligomers were elevated in both the STZ/Saline and STZ/LPS groups (Figure 3C, 3E), 
whereas other Aβ oligomers were only significantly increased in the STZ/Saline group alone (Figure 3B, 3D). Representative 
images can be seen in Figure 3F.  
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